NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Carbamazepine and Vitamin D3: what the published research says

PubMed indexes 2 records that name Carbamazepine and Vitamin D3 together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Carbamazepine and Vitamin D3. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

2 studies naming Carbamazepine and Vitamin D3.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine.

Acta neurologica Scandinavica · 1985 · PMID 2990139

Human subjects

“We conclude that treatment with vitamins D2 and D3 in the same doses produces considerably different serum concentrations of vitamin D metabolites. If the present findings can be extrapolated to normal subjects, it is important to consider more carefully which D-vitamin should be used, both with regard to therapy and supplementation.”

Tjellesen et al. · From the abstract

Names both Carbamazepine and Vitamin D3 in its title.

Brief report: enzyme inducers reduce elimination half-life after a single dose of nevirapine in healthy women.

Journal of acquired immune deficiency syndromes (1999) · 2006 · PMID 16940857

Clinical Trial, Phase I

“Interventions with a single dose of 400 mg of carbamazepine or 184 mg of phenytoin for 3 or 7 days effectively reduced the NVP half-life. Appropriately powered safety and feasibility end point studies are warranted before these interventions can be tested in the setting of single-dose NVP for prevention of mother-to-child transmission (PMTCT) of HIV to reduce the development of NVP resistance.”

L'homme et al. · Authors' conclusion

Names Carbamazepine and Vitamin D3 together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Carbamazepine, Vitamin D3, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.